Recipient
Princess Street Practice
First report 9 Apr 2014•Latest report 9 Apr 2014
Reports, concerns and published responses
Health and care · Healthcare site. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.
- Reports
- 1
- Published responses
- 0%
- Concerns addressed
- 0
- Stated actions
- 0
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Reports over time
Reports over time
Reports naming this recipient by issue year.
Evidence profile
Report topics
Share of this recipient’s reports compared with all other recipients.
Topic comparisons are not available in the current evidence snapshot.
Concerns and recipient responses
Statements from Princess Street Practice linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Addressed to Princess Street Group Practice, now represented here by Princess Street Practice.
Concerns raised2
Failure to establish whether Gabapentin is contraindicated for patients with severe Type 1 diabetes
Lack of prescriber awareness of Gabapentin's rare side effect of precipitating diabetic coma
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026